Peter J. Thurlow

476 total citations
33 papers, 397 citations indexed

About

Peter J. Thurlow is a scholar working on Hematology, Surgery and Immunology and Allergy. According to data from OpenAlex, Peter J. Thurlow has authored 33 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 8 papers in Surgery and 8 papers in Immunology and Allergy. Recurrent topics in Peter J. Thurlow's work include Platelet Disorders and Treatments (13 papers), Cell Adhesion Molecules Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Peter J. Thurlow is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Cell Adhesion Molecules Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Peter J. Thurlow collaborates with scholars based in Australia and United Kingdom. Peter J. Thurlow's co-authors include Gary P. Jamieson, James S. Wiley, Marie B. Snook, Ian F. C. McKenzie, Paul J. Neeson, Andrew Grigg, Tim Brighton, Beng H. Chong, Ross Baker and Anthony J.F. d’Apice and has published in prestigious journals such as Biochemical Journal, American Journal of Physiology-Heart and Circulatory Physiology and Journal of Cellular Physiology.

In The Last Decade

Peter J. Thurlow

33 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Thurlow Australia 13 131 101 80 67 54 33 397
Katarzyna Brzeźniakiewicz‐Janus Poland 11 84 0.6× 152 1.5× 61 0.8× 181 2.7× 35 0.6× 36 430
Lavinia Forte Italy 8 74 0.6× 117 1.2× 5 0.1× 87 1.3× 54 1.0× 10 355
Begoña Hurtado Spain 10 127 1.0× 173 1.7× 4 0.1× 89 1.3× 61 1.1× 19 404
Stefanie Herzog Germany 4 118 0.9× 79 0.8× 3 0.0× 83 1.2× 44 0.8× 4 406
N Gilboa United States 11 39 0.3× 37 0.4× 10 0.1× 72 1.1× 30 0.6× 29 306
Janelle Staton Australia 12 193 1.5× 50 0.5× 4 0.1× 181 2.7× 65 1.2× 15 570
B. Horstkamp Germany 5 46 0.4× 302 3.0× 5 0.1× 92 1.4× 53 1.0× 5 750
Charles R. Kiefer United States 7 111 0.8× 52 0.5× 11 0.1× 88 1.3× 26 0.5× 13 429
Hongxiang Xie China 14 66 0.5× 158 1.6× 3 0.0× 101 1.5× 27 0.5× 21 425
MR Barnard United States 9 433 3.3× 37 0.4× 3 0.0× 20 0.3× 157 2.9× 13 539

Countries citing papers authored by Peter J. Thurlow

Since Specialization
Citations

This map shows the geographic impact of Peter J. Thurlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Thurlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Thurlow more than expected).

Fields of papers citing papers by Peter J. Thurlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Thurlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Thurlow. The network helps show where Peter J. Thurlow may publish in the future.

Co-authorship network of co-authors of Peter J. Thurlow

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Thurlow. A scholar is included among the top collaborators of Peter J. Thurlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Thurlow. Peter J. Thurlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chong, Beng H., et al.. (2005). Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractionated Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis. Journal of Thrombosis and Thrombolysis. 19(3). 173–181. 39 indexed citations
2.
McNicol, P. L., et al.. (1999). The Effect of Preoperative Aspirin and/or Heparin Therapy on Coagulation and Postoperative Blood Loss after Coronary Artery Bypass Surgery. Critical Care and Resuscitation. 1(2). 130–139. 4 indexed citations
3.
Savige, Judy, Pauline Branley, Paul J. Neeson, Stephen R. Holdsworth, & Peter J. Thurlow. (1998). Antithyroid and antiadrenal autoantibodies in antiglomerular basement membrane disease, thin basement membrane disease and Alport syndrome. Pathology. 30(1). 30–33. 2 indexed citations
4.
Thurlow, Peter J.. (1997). Anticoagulation in Older People. The Australian Journal of Hospital Pharmacy. 27(4). 328–334. 1 indexed citations
6.
Jamieson, Gary P., Marie B. Snook, Peter J. Thurlow, & James S. Wiley. (1996). Extracellular ATP causes loss of L-selectin from human lymphocytes via occupancy of P2Z purinoceptors. Journal of Cellular Physiology. 166(3). 637–642. 88 indexed citations
7.
Jamieson, Gary P., Marie B. Snook, Peter J. Thurlow, & James S. Wiley. (1996). Extracellular ATP causes loss of L‐selectin from human lymphocytes via occupancy of P2Z purinoceptors. Journal of Cellular Physiology. 166(3). 637–642. 3 indexed citations
8.
Prince, H. Miles, et al.. (1995). Acquired protein S deficiency in a patient with systemic lupus erythematosus causing central retinal vein thrombosis.. Journal of Clinical Pathology. 48(4). 387–389. 16 indexed citations
9.
Xie, Bing, et al.. (1995). Various cells release a stable small molecule that inhibits endothelium-dependent relaxation. American Journal of Physiology-Heart and Circulatory Physiology. 269(4). H1303–H1311. 1 indexed citations
10.
Wiley, James S., et al.. (1995). Agonists for endothelial P2 purinoceptors trigger a signalling pathway producing Ca2+ responses in lymphocytes adherent to endothelial cells. Biochemical Journal. 311(2). 589–594. 5 indexed citations
11.
Thurlow, Peter J., et al.. (1991). Changes in platelet function and reactivity induced by quinine in relation to quinine (drug) induced immune thrombocytopenia. Thrombosis Research. 61(5-6). 501–514. 12 indexed citations
12.
Bradley, C. J., et al.. (1991). Electron microscopic studies of quinine induced ultrastructural changes to platelets. Thrombosis Research. 63(5). 563–568. 1 indexed citations
13.
Thurlow, Peter J., et al.. (1990). The role of fibronectin in platelet aggregation. British Journal of Haematology. 75(4). 549–556. 20 indexed citations
14.
Grigg, Andrew, et al.. (1989). BLEEDING DUE TO AN ACQUIRED INHIBITOR OF PLATELET ASSOCIATED FACTOR V. Australian and New Zealand Journal of Medicine. 19(4). 310–314. 21 indexed citations
15.
D'Apice, A. J. F., et al.. (1987). TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH A MONOCLONAL ANTIBODY TO A T CELL ANTIGEN (HuLy‐m2). Australian and New Zealand Journal of Medicine. 17(2). 210–215. 7 indexed citations
16.
Scarlett, John D., et al.. (1987). Plasma-dependent and -independent mechanisms of platelet aggregation induced by human tumour cell lines. Thrombosis Research. 46(5). 715–726. 16 indexed citations
17.
Cosgrove, Leah, Peter J. Thurlow, Melinda Lowe, & Ian F. C. McKenzie. (1984). A Monoclonal antibody involved in platelet activation. Pathology. 16(3). 359–359. 1 indexed citations
18.
Thurlow, Peter J., et al.. (1984). A MONOCLONAL ANTIBODY DETECTING A NEW HUMAN T CELL ANTIGEN, HULY-M2. Transplantation. 38(2). 143–147. 14 indexed citations
19.
Thurlow, Peter J., et al.. (1983). Detection of glycoprotein IIb and IIIa by monoclonal antibodies. British Journal of Haematology. 55(1). 123–134. 21 indexed citations
20.
Thurlow, Peter J. & Ian F. C. McKenzie. (1983). MONOCLONAL ANTIBODIES IN CLINICAL MEDICINE – A REVIEW. Australian and New Zealand Journal of Medicine. 13(1). 91–100. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026